celecoxib has been researched along with leukotriene b4 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Boldogh, I; Gessell-Lee, DL; Olano, JP; Peterson, JW; Popov, VL | 1 |
| Beer, DG; Chen, X; Giordano, TJ; Jin, Z; Lin, Y; Lubet, RA; Shih, WC; Sood, S; Wang, P; Wang, S; Wu, N; Yang, CS | 1 |
| Adams, B; Baratelli, F; Dubinett, SM; Mao, JT; Roth, MD; Sarafian, T; Serio, KJ; Tsu, IH | 1 |
| Atilla, G; Baylas, H; Berdeli, AH; Buduneli, E; Buduneli, N; Vardar, S | 1 |
| Cho, YB; Han, CK; Joo, HJ; Jung, IH; Jung, K; Kim, JH; Kwak, WJ; Rhee, HI; Ryu, K | 1 |
| Antunes, E; Camargo, EA; De Nucci, G; Desouza, IA; Franco-Penteado, CF; Lima, CS; Muscará, MN; Teixeira, SA | 1 |
| Lotan, R; Newman, RA; Schroeder, CP; Yang, P | 1 |
| Angioni, C; Coste, O; Geisslinger, G; Groesch, S; Hoernig, M; Maier, TJ; Metzner, J; Pergola, C; Schmidt, R; Steinhilber, D; Tausch, L; Werz, O | 1 |
| Anderson, GD; De Ciechi, PA; Keys, KL; Masferrer, JL | 1 |
| Gao, P; Guan, L; Zheng, J | 1 |
| Fomenko, IS; Panasyuk, NB; Sklyarov, AY | 1 |
| Amin, AR; Dave, M | 1 |
| Bitencourt, Cda S; Faccioli, LH; Nicolete, R; Pereira, PA; Peres-Buzalaf, C; Ramos, SG; Sadikot, R; Secatto, A; Trindade, BC | 1 |
| Arantes, EC; Faccioli, LH; Hori, JI; Paula-Silva, FW; Serezani, CH; Sorgi, CA; Zamboni, DS; Zoccal, KF | 1 |
| Altavilla, D; Arcoraci, V; Bitto, A; Galfo, F; Irrera, N; Macrì, A; Minutoli, L; Pallio, G; Pizzino, G; Squadrito, F; Squadrito, G | 1 |
| Carranza, C; Carreto-Binaghi, LE; Gonzalez, Y; Guzmán-Beltrán, S; Juárez, E; Muñoz-Torrico, M; Sartillo-Mendoza, LG; Torres, M | 1 |
1 trial(s) available for celecoxib and leukotriene b4
| Article | Year |
|---|---|
Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
Topics: Administration, Oral; Aged; Bronchoalveolar Lavage; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Leukotriene B4; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Middle Aged; Pyrazoles; RNA, Messenger; Smoking; Sulfonamides | 2004 |
15 other study(ies) available for celecoxib and leukotriene b4
| Article | Year |
|---|---|
Role of cyclooxygenase enzymes in a murine model of experimental cholera.
Topics: Aldehydes; Animals; Celecoxib; Cholera; Cholera Toxin; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Female; Glutathione; Isoenzymes; Lactones; Leukotriene B4; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred C57BL; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Tumor Necrosis Factor-alpha | 2003 |
Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Topics: Adenocarcinoma; Anastomosis, Surgical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Body Weight; Celecoxib; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Hydroxyurea; Immunohistochemistry; Leukotriene B4; Lipoxygenase Inhibitors; Male; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2004 |
Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Endotoxins; Fatty Acids, Omega-3; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2005 |
SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Depression, Chemical; Diclofenac; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Eicosanoids; Gastric Mucosa; Leukotriene B4; Male; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides | 2005 |
Acute pulmonary inflammation induced by exposure of the airways to staphylococcal enterotoxin type B in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Benzoquinones; Bone Marrow; Bronchoalveolar Lavage Fluid; Celecoxib; Chemotaxis, Leukocyte; Cytokines; Dexamethasone; Dinoprostone; Dose-Response Relationship, Immunologic; Enterotoxins; Intubation, Intratracheal; Leukocyte Count; Leukotriene B4; Lipoxygenase Inhibitors; Male; Neutrophils; Pneumonia, Staphylococcal; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Time Factors | 2006 |
Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines.
Topics: 5-Lipoxygenase-Activating Proteins; Apoptosis; Blotting, Western; Carrier Proteins; Celecoxib; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; Indoles; Leukotriene B4; Lipoxygenase Inhibitors; Lung Neoplasms; Membrane Proteins; Pyrazoles; Quinolines; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2007 |
Celecoxib inhibits 5-lipoxygenase.
Topics: Adult; Animals; Arachidonate 5-Lipoxygenase; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Female; HeLa Cells; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes, Mononuclear; Leukotriene B4; Lipoxygenase Inhibitors; Male; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2008 |
Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arthritis, Experimental; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Epoxide Hydrolases; Humans; Hydroxyurea; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred DBA; Prostaglandins; Pyrazoles; RNA, Messenger; Sulfonamides | 2009 |
Role of leukotriene B4 in celecoxib-mediated anticancer effect.
Topics: Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Male; Masoprocol; Prostatic Neoplasms; Pyrazoles; Sulfonamides | 2010 |
Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis.
Topics: Acetic Acid; Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Arginine; Benzoquinones; Celecoxib; Colitis, Ulcerative; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Female; Guanidines; Indomethacin; Intestine, Large; Leukotriene B4; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Pyrazoles; Rats; Sulfonamides | 2011 |
Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib.
Topics: Celecoxib; Cells, Cultured; Chondrocytes; Dinoprost; Dinoprostone; Humans; Inflammation Mediators; Interleukin-1beta; Knee; Leukotriene B4; Nitric Oxide; Osteoarthritis; Prostaglandin D2; Prostaglandins F; Pyrazoles; Sulfonamides; Thromboxane B2 | 2013 |
Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Histoplasma; Histoplasmosis; Interferon-gamma; Leukotriene B4; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Nitric Oxide; Pyrazoles; Sulfonamides | 2013 |
Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality.
Topics: Animals; Arachidonate 5-Lipoxygenase; Blotting, Western; Carrier Proteins; Celecoxib; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dinoprostone; In Vitro Techniques; Indoles; Indomethacin; Inflammasomes; Interleukin-1beta; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Macrophages, Peritoneal; Mice; Mice, Knockout; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphoproteins; Prostaglandin Antagonists; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Reverse Transcriptase Polymerase Chain Reaction; Scorpion Stings; Scorpion Venoms; Scorpions; Xanthones | 2016 |
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Body Weight; Catechin; CD3 Complex; Celecoxib; Colitis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Combinations; Eating; Gene Expression Regulation; Hydroxyurea; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Thromboxane B2; Tumor Necrosis Factor-alpha | 2016 |
Exploring COX-2 inhibitors in tuberculosis: A whole-blood model approach for immune response and adjunt therapy evaluation.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Immunity; Inflammation; Leukotriene B4; Mycobacterium tuberculosis; Tuberculosis; Tumor Necrosis Factor-alpha | 2023 |